| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-0327(00)00367-0 |
| P698 | PubMed publication ID | 11246075 |
| P2093 | author name string | Fink M | |
| P2860 | cites work | Old and new information about electroshock | Q80741081 |
| Pseudo-dementia | Q28203393 | ||
| ECT and intracranial vascular masses | Q30599209 | ||
| ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk | Q33951124 | ||
| Is Unilateral ECT Less Effective Than Bilateral ECT? | Q33989391 | ||
| Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine | Q34048732 | ||
| Meduna and the origins of convulsive therapy | Q34248290 | ||
| Does ECT alter brain structure? | Q34328727 | ||
| Comparative study of chlorpromazine and insulin coma in therapy of psychosis | Q34538747 | ||
| Electroconvulsive therapy and memory loss: a personal journey | Q38578006 | ||
| Prospective electroconvulsive therapy in a delusional depressed patient with a frontal meningioma. A case report | Q39620130 | ||
| Delusional Depressions: Natural History and Response to Treatment | Q39710242 | ||
| Neuroendocrine predictors of electroconvulsive therapy outcome. Dexamethasone suppression test and prolactin | Q39733069 | ||
| Cholinergic aspects of convulsive therapy | Q40037663 | ||
| Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience | Q40808838 | ||
| Convulsive therapy in schizophrenia? | Q41018853 | ||
| Diencephalic stimulation and the effects of ECT in endogenous depression | Q41048381 | ||
| The dexamethasone suppression test in patients with mood disorders. | Q41203480 | ||
| A neuroendocrine view of ECT. | Q41219310 | ||
| Rapid psychotherapeutic effects of anesthesia with isoflurane (ES narcotherapy) in treatment-refractory depressed patients | Q41481561 | ||
| A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions | Q41531201 | ||
| Electrode placement in ECT: cognitive effects | Q45170667 | ||
| The factor of hypoxemia in electroshock therapy. | Q51346688 | ||
| Antidepressant and cognitive effects of twice- versus three-times- weekly ECT | Q51607492 | ||
| Comparison of bifrontal and bitemporal ECT for major depression. | Q51978776 | ||
| The history of electroconvulsive therapy in the United States and its place in American psychiatry: a personal memoir. | Q51984174 | ||
| Memory and ECT: from polarization to reconciliation. | Q52026272 | ||
| CURARE: A PREVENTIVE OF TRAUMATIC COMPLICATIONS IN CONVULSIVE SHOCK THERAPY | Q57487858 | ||
| Depression, Delusions, and Drug Response | Q66896129 | ||
| Reduced length and cost of hospital stay for major depression in patients treated with ECT | Q69107508 | ||
| EEG seizure patterns during multiple unilateral and bilateral ECT | Q69486071 | ||
| Studies of dosage, seizure threshold, and seizure duration in ECT | Q69744496 | ||
| Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy | Q70580672 | ||
| A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities | Q73782396 | ||
| Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects | Q73782400 | ||
| Increased neurogenesis in a model of electroconvulsive therapy | Q73914669 | ||
| Evaluation of convulsive and subconvulsive shock therapies utilizing a control group | Q73955121 | ||
| Relation of electroencephalographic delta activity to behavioral response in electroshock; quantitative serial studies | Q74627710 | ||
| Succinyl-choline-iodide as a muscular relaxant in electroshock therapy | Q76087396 | ||
| P433 | issue | 1-3 | |
| P304 | page(s) | 1-15 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Journal of Affective Disorders | Q15716493 |
| P1476 | title | Convulsive therapy: a review of the first 55 years | |
| P478 | volume | 63 |
| Q56080509 | A Western Australian Survey On Public Attitudes Toward and Knowledge of Electroconvulsive Therapy |
| Q99572443 | A pilot study of magnetic seizure therapy for treatment-resistant obsessive-compulsive disorder |
| Q38746838 | A retrospective chart audit of electroconvulsive therapy at a regional Australian hospital |
| Q90613762 | Acute Phase Treatment Outcomes of Electroconvulsive Therapy in Adolescents and Young Adults |
| Q35580600 | Advances in the Management of Treatment-Resistant Depression |
| Q34496251 | Advances in the treatment of depression |
| Q50949237 | Age-related cognitive effects of ECT and ECT-induced mood improvement in depressive patients. |
| Q43962908 | Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model |
| Q34240963 | Bipolar disorders: new approaches to therapy |
| Q48219342 | Brain stimulation in psychiatry and its effects on cognition |
| Q37784139 | Clinical manifestations, diagnosis, and empirical treatments for catatonia |
| Q24599783 | Contemporary use and practice of electroconvulsive therapy worldwide |
| Q51871308 | ECT: shocked beyond belief. |
| Q48242551 | Effect of electroconvulsive seizures on pattern separation. |
| Q48465348 | Effects of repeated electroconvulsive shocks on catecholamine systems: electrophysiological studies in the rat brain |
| Q42682557 | Electroconvulsive Therapy Alters Dopamine Signaling in the Striatum of Non-human Primates |
| Q46522545 | Electroconvulsive stimulations prevent stress-induced morphological changes in the hippocampus |
| Q37676861 | Electroconvulsive therapy and nursing care |
| Q55008047 | Electroconvulsive therapy in 77-year-old patient with pacemaker: a case report. |
| Q48449500 | Electroconvulsive therapy without consent from patients: one-year follow-up study |
| Q47721474 | Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy |
| Q28247614 | Emerging targets for antidepressant therapies |
| Q36655168 | Emerging treatments for depression |
| Q36832348 | Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review |
| Q37648736 | Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature |
| Q35236701 | Future prospects in depression research |
| Q35187929 | GABAergic dysfunction in mood disorders. |
| Q48466340 | Historical essay: electroconvulsive therapy, memory, and self in America |
| Q47804337 | I was told it restarts your brain: knowledge, power, and women's experiences of ECT. |
| Q50016766 | I'm shocked: informed consent in ECT and the phenomenological-self |
| Q47596191 | Impacts of Electroconvulsive Therapy on 1-Year Outcomes in Patients With Schizophrenia: A Controlled, Population-Based Mirror-Image Study. |
| Q36411952 | Is electroconvulsive therapy an evidence-based treatment for catatonia? A systematic review and meta-analysis |
| Q48662368 | Italian psychiatry in an international context: Ugo Cerletti and the case of electroshock |
| Q38006709 | Kalirin, a key player in synapse formation, is implicated in human diseases |
| Q43958216 | Long-Term Results of Electroconvulsive Therapy in Severe Gilles de la Tourette Syndrome |
| Q34760553 | Lorazepam provocation test in purported schizophrenia with lack of treatment response |
| Q37949624 | Magnetic seizure therapy for treatment-resistant depression. |
| Q42694571 | Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. |
| Q36395636 | Neuromodulation therapies and treatment-resistant depression |
| Q37957197 | Neuromuscular blocking agents for electroconvulsive therapy: a systematic review |
| Q51922049 | Neuropsychological changes following electrical injury. |
| Q33749527 | Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review |
| Q44374786 | Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression |
| Q35538970 | New Aspects of Neurotransmitter Release and Exocytosis: Dynamic and Differential Regulation of Synapsin I Phosphorylation by Acute Neuronal Excitation In Vivo |
| Q35236721 | Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities |
| Q48825646 | Patients' perceptions of the process of consenting to electroconvulsive therapy |
| Q45082550 | Pharmacologically-induced neurocatastrophes |
| Q36514378 | Practice of Acute and Maintenance Electroconvulsive Therapy in the Psychiatric Clinic of a University Hospital from Turkey: between 2007 and 2013 |
| Q34574208 | Pre-treatment amygdala volume predicts electroconvulsive therapy response |
| Q39157238 | Prolonged apnea during electroconvulsive therapy in monozygotic twins: case reports. |
| Q37196357 | Reasons for referral for electroconvulsive therapy: a comparison between adolescents and adults |
| Q47568297 | Resolution of severe psychogenic dysphagia with ECT in an elderly patient |
| Q48056489 | Spatial memory impairment in Morris water maze after electroconvulsive seizures |
| Q47311400 | Systematic evaluation of skeletal fractures caused by induction of electroconvulsive seizures in rat state a need for attention and refinement of the procedure |
| Q55365797 | The Immediate Early Gene Egr3 Is Required for Hippocampal Induction of Bdnf by Electroconvulsive Stimulation. |
| Q33337849 | The beginnings of modern psychiatric treatment in Europe. Lessons from an early account of convulsive therapy |
| Q34615947 | Therapeutic options for treatment-resistant depression |
| Q37612338 | Toxoplasmosis Infection and Cognitive Deficit after Electroconvulsive Treatment (ECT), Is There a Connection? |
| Q57644791 | Transcranial Direct Current Stimulation for the Treatment of Depression: a Comprehensive Review of the Recent Advances |
| Q35997448 | Treatment-resistant depression: therapeutic trends, challenges, and future directions |
| Q50587756 | Treatment-resistant, five-year long, postpartum-onset Capgras episode resolving after electroconvulsive therapy. |
| Q34817435 | Vertebrates used for medicinal purposes by members of the Nyishi and Galo tribes in Arunachal Pradesh (North-East India). |
| Q31121208 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder |
| Q38123516 | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders |
| Q50872808 | [Electroconvulsive therapy and level of evidence: From causality to dose-effect relationship]. |
| Q79863885 | [None fly over the cuckoo's nest anymore. Electroconvulsive therapy and anesthesia] |
Search more.